跳至主要内容
临床试验/EUCTR2004-000023-15-IT
EUCTR2004-000023-15-IT进行中(未招募)不适用

A comparison of CS 747 and Clopidogrelin Acute coronary syndrome sujects who are to undergo percutaneous coronary intervention/TIMI-38

ELI LILLY0 个研究点开始时间: 2005年5月18日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
ELI LILLY

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
ELI LILLY

相似试验

进行中(未招募)
1 期
A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention - TRITON; TIMI 38; TAA
EUCTR2004-000023-15-ESilly S.A.13,000
进行中(未招募)
不适用
A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention - TRITON; TIMI 38; TAAReduction of atherothrombotic events in patients with acute coronary syndromes (ACS) that is patients with ST-segment elevation MI [STEMI], non-ST-segment elevation MI [NSTEMI], or unstable angina [UA], who are to undergo percutaneous coronary intervention (PCI).MedDRA version: 7.0Level: HLTClassification code 10011085
EUCTR2004-000023-15-SKEli Lilly and Company Limited13,000
进行中(未招募)
不适用
A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention - TRITON; TIMI 38; TAA
EUCTR2004-000023-15-LTEli Lilly and Company Limited14,200
进行中(未招募)
1 期
A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention - TRITON; TIMI 38; TAAReduction of atherothrombotic events in patients with acute coronary syndromes (ACS) that is patients with ST-segment elevation MI [STEMI], non-ST-segment elevation MI [NSTEMI], or unstable angina [UA], who are to undergo percutaneous coronary intervention (PCI).MedDRA version: 7.0Level: HLTClassification code 10011085
EUCTR2004-000023-15-ISEli Lilly and Company Limited13,000
进行中(未招募)
不适用
A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention - TRITON; TIMI 38; TAAReduction of atherothrombotic events in patients with acute coronary syndromes (ACS) that is patients with ST-segment elevation MI [STEMI], non-ST-segment elevation MI [NSTEMI], or unstable angina [UA], who are to undergo percutaneous coronary intervention (PCI).MedDRA version: 7.0Level: HLTClassification code 10011085
EUCTR2004-000023-15-CZEli Lilly and Company Limited14,200
A comparison of CS 747 and Clopidogrelin Acute... | 临床试验